chr5-13841919-AA-AAAA
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_001369.3(DNAH5):c.5272-16_5272-15dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.015 ( 52 hom., cov: 0)
Exomes 𝑓: 0.019 ( 4 hom. )
Consequence
DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.617
Publications
0 publications found
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.129 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001369.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.0149 AC: 1561AN: 104512Hom.: 52 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1561
AN:
104512
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0188 AC: 9070AN: 483186Hom.: 4 Cov.: 0 AF XY: 0.0190 AC XY: 4974AN XY: 261124 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
9070
AN:
483186
Hom.:
Cov.:
0
AF XY:
AC XY:
4974
AN XY:
261124
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
181
AN:
12424
American (AMR)
AF:
AC:
342
AN:
19022
Ashkenazi Jewish (ASJ)
AF:
AC:
220
AN:
13720
East Asian (EAS)
AF:
AC:
1154
AN:
26324
South Asian (SAS)
AF:
AC:
1500
AN:
44638
European-Finnish (FIN)
AF:
AC:
579
AN:
26480
Middle Eastern (MID)
AF:
AC:
43
AN:
1976
European-Non Finnish (NFE)
AF:
AC:
4608
AN:
313480
Other (OTH)
AF:
AC:
443
AN:
25122
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.326
Heterozygous variant carriers
0
560
1120
1679
2239
2799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0149 AC: 1560AN: 104506Hom.: 52 Cov.: 0 AF XY: 0.0163 AC XY: 768AN XY: 47190 show subpopulations
GnomAD4 genome
AF:
AC:
1560
AN:
104506
Hom.:
Cov.:
0
AF XY:
AC XY:
768
AN XY:
47190
show subpopulations
African (AFR)
AF:
AC:
341
AN:
28146
American (AMR)
AF:
AC:
74
AN:
8688
Ashkenazi Jewish (ASJ)
AF:
AC:
46
AN:
2960
East Asian (EAS)
AF:
AC:
434
AN:
3100
South Asian (SAS)
AF:
AC:
58
AN:
2692
European-Finnish (FIN)
AF:
AC:
55
AN:
1888
Middle Eastern (MID)
AF:
AC:
3
AN:
154
European-Non Finnish (NFE)
AF:
AC:
506
AN:
54722
Other (OTH)
AF:
AC:
17
AN:
1392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
Primary ciliary dyskinesia 3 (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.